 | Up a level |
Ghaedi, F. and Etesami, I. and Aryanian, Z. and Kalantari, Y. and Goodarzi, A. and Teymourpour, A. and Tavakolpour, S. and Mahmoudi, H. and Daneshpazhooh, M. (2021) Drug-induced pemphigus: A systematic review of 170 patients. International Immunopharmacology, 92.
Nobari, N.N. and Montazer, F. and Seirafianpour, F. and Nikkhah, F. and Aryanian, Z. and Goodarzi, A. (2021) Histopathologic changes and cellular events of organs systems in COVID-19. Journal of Cellular and Molecular Anesthesia, 6 (1). pp. 81-88.
Aryanian, Z. and Balighi, K. and Daneshpazhooh, M. and Karamshahi, E. and Hatami, P. and Goodarzi, A. and Tajalli, M. and Vance, T.M. (2021) Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: A retrospective study. International Immunopharmacology, 96.
Aryanian, Z. and Keramatipour, M. and Esmaili, N. and Goodarzi, A. and Azizpour, A. and Etesami, I. and Damavandi, M.R. and Zarrinrad, G. and Ahmadloo, S. and Ghandi, N. (2020) Is there any association between a vitamin D receptor gene polymorphism (FokI) and pemphigus vulgaris? Iranian Journal of Dermatology, 23 (2). pp. 49-55.
Azizpour, A. and Aryanian, Z. and Nikoo, A. and Nasimi, M. and Goodarzi, A. and Etesami, I. (2020) Porokeratotic eccrine ostial and dermal duct nevus with extensive linear distribution: A case report. Iranian Journal of Dermatology, 23 (2). pp. 80-82.
